182 related articles for article (PubMed ID: 31670968)
1. An Aseptic One-Shot Bottom-Up Method To Produce Progesterone Nanocrystals: Controlled Size and Improved Bioavailability.
Zhai J; Li Q; Xu H; Su T; Wang YE; Huang W; Ma Y; Guan S
Mol Pharm; 2019 Dec; 16(12):5076-5084. PubMed ID: 31670968
[TBL] [Abstract][Full Text] [Related]
2. Naproxen Microparticulate Systems Prepared Using In Situ Crystallisation and Freeze-Drying Techniques.
Solaiman A; Tatari AK; Elkordy AA
AAPS PharmSciTech; 2017 Jul; 18(5):1438-1446. PubMed ID: 28004343
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
4. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
5. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
[TBL] [Abstract][Full Text] [Related]
6. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
7. Nanosizing techniques for improving bioavailability of drugs.
Al-Kassas R; Bansal M; Shaw J
J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
[TBL] [Abstract][Full Text] [Related]
8. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
9. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
10. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
[TBL] [Abstract][Full Text] [Related]
13. Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.
de Waard H; Grasmeijer N; Hinrichs WL; Eissens AC; Pfaffenbach PP; Frijlink HW
Eur J Pharm Sci; 2009 Oct; 38(3):224-9. PubMed ID: 19631270
[TBL] [Abstract][Full Text] [Related]
14. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying.
de Waard H; Hinrichs WL; Frijlink HW
J Control Release; 2008 Jun; 128(2):179-83. PubMed ID: 18423767
[TBL] [Abstract][Full Text] [Related]
15. Active freeze drying for production of nanocrystal-based powder: A pilot study.
Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
[TBL] [Abstract][Full Text] [Related]
16. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
17. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size.
Sinha B; Müller RH; Möschwitzer JP
Int J Pharm; 2013 Aug; 453(1):126-41. PubMed ID: 23333709
[TBL] [Abstract][Full Text] [Related]
18. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
[TBL] [Abstract][Full Text] [Related]
19. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization.
Li Y; Zhao X; Zu Y; Zhang Y
Int J Pharm; 2015 Jul; 490(1-2):324-33. PubMed ID: 26027492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
